Condition: Arrhythmias, Cardiac · Paroxysmal Atrial Fibrillation · Sponsor: Insight Medtech Co., Ltd.
This trial aims to determine whether the InsightPFA for PVI is as effective and safe as standard RFA in the treatment of symptomatic paroxysmal AF.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Beijing Anzhen Hospital | Beijing, Beijing Municipality, China | — |
| Xiamen Cardiovascular Hospital, Xiamen University | Xiamen, Fujian, China | — |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | — |
| Nanfang Hospital, Southern Medical University | Guangzhou, Guangdong, China | — |
| The First Affiliated Hospital of Dalian Medical University | Dalian, Liaoning, China | — |
| Weifang People's Hospital | Weifang, Shandong, China | — |
| Shanghai Zhongshan Hospital | Shanghai, Shanghai Municipality, China | — |
| Yan'an Affiliated Hospital of Kunming Medical University | Kunming, Yunnan, China | — |
| Sir Run Run Shaw Hospital | Hanzhou, Zhejiang, China | — |
| The Affiliated People's Hospital of Ningbo University | Ningbo, Zhejiang, China | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.